--2024/Q4-- / 4.133B--
Nov 6, 20242024/Q3-- / 4.128B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--
Jan 31, 20242023/Q44.457B / 4.010B--
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 18.150
- +0.910+5.28%
Close Oct 15 16:00 ET
- 17.780
- -0.370-2.04%
Post 18:29 ET
20.56BMarket Cap-46538P/E (TTM)
18.170High17.290Low8.97MVolume17.400Open17.240Pre Close160.77MTurnover0.80%Turnover RatioLossP/E (Static)1.13BShares19.08052wk High3.23P/B20.44BFloat Cap8.05552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM5.10%Amplitude3.107Historical Low17.925Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Teva Pharmaceutical Industries Q3 2024 Estimates Date
Currency：USDNov 6, 2024
| Estimate | YoY | |
| Revenue | 4.13B | +7.22% |
| EPS | -<0.01 | -110.71% |
Analyst Rating
Oct 15, 2024
Teva Pharmaceutical Industries Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Teva Pharmaceutical Industries Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
